Mikrometastaser ved brystkreft
- Prosjektnummer
- 2009025
- Ansvarlig person
- Rolf Kåresen
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Nytt flerårig forskningsprosjekt
- Helsekategori
- Cancer
- Forskningsaktivitet
- 5. Treatment Developement
Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles.
Breast Cancer Res 2011;13(4):R75. Epub 2011 aug 4
PMID: 21816090
High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer.
Int J Cancer 2012 Aug;131(4):E405-15. Epub 2011 nov 9
PMID: 21935921
Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern.
Breast Cancer Res Treat 2011 Feb;125(3):729-38. Epub 2010 mai 7
PMID: 20449649
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables.
Mol Oncol 2011 Feb;5(1):77-92. Epub 2010 des 2
PMID: 21169070
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.
Sci Transl Med 2010 Jun;2(38):38ra47.
PMID: 20592421
Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer.
Mol Oncol 2011 Feb;5(1):61-76. Epub 2010 nov 25
PMID: 21212030
The prognostic impact of occult nodal metastasis in early breast carcinoma.
Breast Cancer Res Treat 2009 Nov;118(1):57-66. Epub 2009 feb 15
PMID: 19219629
ArrayCHG analysis of immunomagnetic isolated breast cancer cells from sentinel lymph node and bone mrow
Poster: AACR 18-22april 2009, Denver Colorado
Detection and caracterization of tumotr celles in sentinel lymph nodes and bone marrow of patients with breast cancer
Poster presentation: 7th International Sympåosium on Minimal Residual Cancer, Settember 16-19, 2009. Athens, Greece
Detection, isolation an characterization of micrometastaic cells
- Disputert:
- august 2011
- Hovedveileder:
- Øystein Fodsatd
PhD
- Disputert:
- september 2009
- Hovedveileder:
- Toril Sauer
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport